Buy Granules India Ltd For Target Rs. 415 - Religare Broking
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/10/2234e61a014d582cbe65d63ce9b35d19.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Granules India Ltd. (GRANULES)
* Granules has been trading in a steady long term uptrend since 2012, after spending nearly 7 years in a prolonged consolidation phase after listing.
* It usually witnesses time-wise correction after a strong directional up move. And, in line with past instances, it has been trading with a corrective bias for nearly two years, to digest the phenomenal surge from roughly 80 levels to a new record high of 433 levels.
* It is currently hovering around the trendline hurdle and the recent surge post base formation around the 300 levels indicates the prevailing momentum to extend further. We thus recommend accumulating fresh in the given range.
Buy Granules India Ltd - Target : 415, Stop Loss : 315, CMP : 346 Range : 346-348, Period : 1 Month
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://www.religareonline.com/disclaimer
SEBI Registration number is INZ000174330
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)